The FTI is fairly constant throughout pregnancy, simple to perform, and supplements f-TAPSE with a calibration of heart size, making it a more sensitive measurement. We suggest adding the FTI to fetal heart functional assessment in healthy and pathological cases. Objectives: Various tests are applied to evaluate fetal heart function in cases of cardiac and extra-cardiac disorders: MPI and SF in the left ventricle and f-TAPSE to right heart assessment. We devised an index adjusting f-TAPSE for the size of the heart by calibrating the measure to heart length, thus obtaining a sensitive index in cases where heart dimensions deviate from normal for GA or EFW. We aimed to evaluate the f-TAPSE index (FTI) in pathological cases of CHD and extracardiac disorders such as TTTS, diaphragmatic hernia, placental tumours, fetal anemia, and others. Methods: F-TAPSE was obtained for 132 fetuses with known cardiac structural defects or dysfunction presenting for follow-up. CRL up to 14 weeks and EFW thereafter, were recorded. Fetal heart length was measured in the 4CV plane on the pericardium, from the base to the apex, at the front or rear apex. The f-TAPSE result was divided by heart length, and then plotted against FTI gestational age scatterplots created from 433 normal fetuses. Results: 132 cases were examined, GA range 11-40 weeks. Deviation from the interquartile range calculated in normal fetuses (0.15-0.26) was observed in pathological cases that showed impaired heart function. In some cases, the index was extremely low, although conventional f-TAPSE measurement was borderline or even within normal range.

